Journal of Diagnostics Concepts & Practice ›› 2022, Vol. 21 ›› Issue (03): 367-373.doi: 10.16150/j.1671-2870.2022.03.013
• Original articles • Previous Articles Next Articles
LIU Xin, QI Caihui, WANG Zhenjing, LÜ Na, WANG Shaoting, WANG Shuping()
Received:
2022-02-01
Online:
2022-06-25
Published:
2022-08-17
Contact:
WANG Shuping
E-mail:dqwg@163.com
CLC Number:
LIU Xin, QI Caihui, WANG Zhenjing, LÜ Na, WANG Shaoting, WANG Shuping. Transcriptome study of glucagon like peptide-1 agonist Exendin-4 on mouse embryonic osteoblast precursor MC3T3-E1 in vitro[J]. Journal of Diagnostics Concepts & Practice, 2022, 21(03): 367-373.
引物 | 序列 |
---|---|
Id3-F | 5′ACTTACCCTGAACTCAACGC3′ |
Id3-R | 5′CTCCAAGGAAACCAGAAGAA3′ |
Rhbdl3-F | 5′GCCTTGTGCTGTCCATACCC3′ |
Rhbdl3-R | 5′CTCATCCTCCTGCCTCCCTC3′ |
Tbata-F | 5′GGAACCAGCCCCTGTTTCTG3′ |
Tbata-R | 5′TCATCCCTACGAGGTGCTAA3′ |
Col14a1-F | 5′TCACGGGTGTTCAGAAATAA3′ |
Col14a1-R | 5′AAAGCAATCCCTGTAAGTCG3′ |
Cxcr2-F | 5′AGATGGCTCAGTGGGTAAGA3′ |
Cxcr2-R | 5′ATGTGGTTGCTGGGATTTGA3′ |
Pag1-F | 5′AACACCCGTGTCAGTTCCTT3′ |
Pag1-R | 5′TCTGTGCCTCAGTTTCTCCA3′ |
Plxnb3-F | 5′CCTTGGTGGAATACAAAGTG3′ |
Plxnb3-R | 5′AATACAGTGGGAAAGAGGGT3′ |
Hp-F | 5′GACCTTCTCAATCTCCACCAGC3′ |
Hp-R | 5′ATCTCCCGCCACGGACTCAC3′ |
Igf2bp2-F | 5′CGCTTGAGTAACCGAGTGTA3′ |
Igf2bp2-R | 5′TCCTTATCTCCCTCCTAACC3′ |
Igfbp7-F | 5′GAGGGCATCAACCACTGTAA3′ |
Igfbp7-R | 5′TCTCCTCTAAGTAAGGAGGACG3′ |
Prss53-F | 5′GCTCTGGCTCCTCAGCGAAGT3′ |
Prss53-R | 5′ATGGTTCCTGGTTGGACTGC3′ |
Rgs14-F | 5′GTTTGCCTACCCATTCCTCC3′ |
Rgs14-R | 5′CCAGTACACCCAGGTCTTACTTAT3′ |
Hoxb8-F | 5′CCGCTAGTGGTAGTATCTCGTAA3′ |
Hoxb8-R | 5′TAGGCAGTTTCATGTTGTTGG3′ |
MTI-F | 5′CGTGCTGTGCCTGATGTGAC3′ |
MT1-R | 5′TAGGAAGACGCTGGGTTGGT3′ |
FXYD7-F | 5′TGGAGAAGGAGACCAGGAGATG3′ |
FXYD7-R | 5′CAGAGTGCAGGAACCAGAGGAC3′ |
[1] |
Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects[J]. J Clin Invest, 2005, 115(12):3318-3325.
doi: 10.1172/JCI27071 URL |
[2] | 中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊疗指南(2017)[J]. 中国骨质疏松杂志, 2019, 25(3):281-309. |
Osteoporosis and bone mineral Disease Branch of Chinese Medical Association. Guidelines for the diagnosis and management of primary osteoporosis (2017)[J]. Chin J Osteoporos, 2019, 25(3):281-309. | |
[3] | 朱洁云, 高敏, 宋秋韵, 等. 中国老年人骨质疏松症患病率的Meta分析[J]. 中国全科医学, 2022, 25(3):346-353. |
Zhu JY, Gao M, Song QY, et al. Prevalence of Osteoporosis in Chinese Elderly People: a Meta-analysis[J]. Chin Gen Pract, 2022, 25(3):346-353. | |
[4] |
Drucker DJ. Minireview: the glucagon-like peptides[J]. Endocrinology, 2001, 142(2):521-527.
pmid: 11159819 |
[5] |
Ma X, Meng J, Jia M, et al. Exendin-4, a glucagon-like peptide-1 receptor agonist, prevents osteopenia by promoting bone formation and suppressing bone resorption in aged ovariectomized rats[J]. J Bone Miner Res, 2013, 28(7):1641-1652.
doi: 10.1002/jbmr.1898 URL |
[6] | Gao L, Li S, Li Y. Exendin-4 promotes the osteogenic differentiation of osteoblasts via the Hedgehog/Gli1 signaling pathway[J]. Am J Transl Res, 2018, 10(1):315-324. |
[7] |
Chen JH, Shen C, Oh H, et al. Exendin-4, a glucagon-like peptide receptor agonist, facilitates osteoblast diffe-rentiation via connexin43[J]. Endocrine, 2021, 72(3):672-680.
doi: 10.1007/s12020-021-02664-7 URL |
[8] |
Manolagas SC. Birth and death of bone cells: basic regu-latory mechanisms and implications for the pathogenesis and treatment of osteoporosis[J]. Endocr Rev, 2000, 21(2):115-137.
pmid: 10782361 |
[9] |
Xie B, Chen S, Xu Y, et al. The Impact of Glucagon-like peptide 1 receptor agonists on bone metabolism and its possible mechanisms in osteoporosis treatment[J]. Front Pharmacol, 2021, 12:697442.
doi: 10.3389/fphar.2021.697442 URL |
[10] |
Nuche-Berenguer B, Lozano D, Gutiérrez-Rojas I, et al. GLP-1 and exendin-4 can reverse hyperlipidic-related osteopenia[J]. J Endocrinol, 2011, 209(2):203-210.
doi: 10.1530/JOE-11-0015 pmid: 21372151 |
[11] |
Feng Y, Su L, Zhong X, et al. Exendin-4 promotes proli-feration and differentiation of MC3T3-E1 osteoblasts by MAPKs activation[J]. J Mol Endocrinol, 2016, 56(3):189-199.
doi: 10.1530/JME-15-0264 URL |
[12] |
Guder C, Gravius S, Burger C, et al. Osteoimmunology: a current update of the interplay between bone and the immune system[J]. Front Immunol, 2020, 11:58.
doi: 10.3389/fimmu.2020.00058 URL |
[13] | Lerner UH. Osteoclasts in health and disease[J]. Pediatr Endocrinol Rev, 2019, 17(2):84-99. |
[14] | 邓禹, 黄禾, 金鸿雁. 绝经后女性骨质疏松相关基因的生物信息学分析[J]. 生殖医学杂志, 2021, 30(10):1341-1348. |
Deng Y, Huang H, Jin HY. Bioinformatics analysis of osteoporosis-related genes in postmenopausal women[J]. J Reprod Med, 2021, 30(10):1341-1348. | |
[15] | Pereira RC, Canalis E. Parathyroid hormone increases mac25/insulin-like growth factor-binding protein-related protein-1 expression in cultured osteoblasts[J]. Endocrino-logy, 1999, 140(5):1998-2003. |
[16] | Ye C, Hou W, Chen M, et al. IGFBP7 acts as a negative regulator of RANKL-induced osteoclastogenesis and oestrogen deficiency-induced bone loss[J]. Cell Prolif, 2020, 53(2):e12752. |
[17] |
Chen Z, Li L, Wu W, et al. Exercise protects proliferative muscle satellite cells against exhaustion via the Igfbp7-Akt-mTOR axis[J]. Theranostics, 2020, 10(14):6448-6466.
doi: 10.7150/thno.43577 pmid: 32483463 |
[18] | 陈亚辉, 龚忠勤, 崔燎. PI3 K/Akt 信号通路在骨质疏松病理过程中的作用[J]. 中国骨质疏松杂志, 2015(3):356-360. |
Chen YH, Gong ZQ, Cui L. Effect of PI3K/Akt pathway on the pathological development of osteoporosis[J]. Chin J Osteoporos, 2015(3):356-360. | |
[19] |
Tateishi K, Nakamura T, Juratli TA, et al. PI3K/AKT/mTOR pathway alterations promote malignant progression and xenograft formation in oligodendroglial tumors[J]. Clin Cancer Res, 2019, 25(14):4375-4387.
doi: 10.1158/1078-0432.CCR-18-4144 pmid: 30975663 |
[20] | 陈露华, 唐宏宇. 补骨脂素对绝经后大鼠骨质疏松及PI3K/Akt/mTOR信号通路的影响[J]. 中国药房, 2021, 32(6):697-701. |
Chen LH, Tang HY. Effect of Psoralen on Osteoporosis in postmenopausal rats and PI3K/Akt/mTOR signaling pathway[J]. China Pharm, 2021, 32(6):697-701. | |
[21] |
Baniwal SK, Shah PK, Shi Y, et al. Runx2 promotes both osteoblastogenesis and novel osteoclastogenic signals in ST2 mesenchymal progenitor cells[J]. Osteoporos Int, 2012, 23(4):1399-1413.
doi: 10.1007/s00198-011-1728-5 pmid: 21881969 |
[1] | YANG Ruixin, DU Yutong, YAN Ranlin, ZHU Zhenggang, LI Chen, YU Yingyan. Improving exploration of biological sample pretreatment in single-cell transcriptome sequencing of gastrointestinal tumors [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(05): 567-574. |
[2] | Chinese Society of Endocrinology,Chinese Medical Association , et al . Expert suggestion for osteoporosis management during the recent COVID-19 pandemic [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 133-135. |
[3] | WEI Ruoqu, YU Hong, YAO Zhirong. Fibroblastic connective tissue nevus in children: a case report and literature review [J]. Journal of Diagnostics Concepts & Practice, 2021, 20(02): 190-194. |
[4] | . [J]. Journal of Diagnostics Concepts & Practice, 2015, 14(03): 248-251. |
[5] | . [J]. Journal of Diagnostics Concepts & Practice, 2015, 14(02): 113-119. |
[6] | . [J]. Journal of Diagnostics Concepts & Practice, 2014, 13(02): 166-170. |
[7] | . [J]. Journal of Diagnostics Concepts & Practice, 2014, 13(01): 68-71. |
[8] | . [J]. Journal of Diagnostics Concepts & Practice, 2013, 12(03): 290-293. |
[9] | . [J]. Journal of Diagnostics Concepts & Practice, 2013, 12(03): 284-289. |
[10] | . [J]. Journal of Diagnostics Concepts & Practice, 2013, 12(02): 205-209. |
[11] | . [J]. Journal of Diagnostics Concepts & Practice, 2012, 11(01): 62-66. |
[12] | . [J]. Journal of Diagnostics Concepts & Practice, 2010, 9(05): 477-481. |
[13] | . [J]. Journal of Diagnostics Concepts & Practice, 2008, 7(06): 628-632. |
[14] | . [J]. Journal of Diagnostics Concepts & Practice, 2006, 5(03): 230-233. |
[15] | . [J]. Journal of Diagnostics Concepts & Practice, 2003, 2(03): 44-46. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||